HR 1349
Women’s Protection in Telehealth Act
Summary
Women’s Protection in Telehealth Act This bill excludes providers of abortion-inducing drugs from participating in Medicare unless the provider is a physician who physically examines the patient, is physically present when the drug is administered, and schedules an in-person follow-up visit with the patient within 14 days of administering the drug.
Bill status
- Status
- In committee
- Sponsor
- Rep. W. Gregory Steube [R-FL-17]
- Cosponsors
- 7
- Policy area
- Health
- Introduced
- 2025-02-13
- Latest action
- 2025-02-13: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committee referrals
Recent actions
- 2025-02-13: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-13: Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-13: Introduced in House
- 2025-02-13: Introduced in House